YOLFTbeta
BR

BrainCool AB

BRAIN · ST · Healthcare / Medical Devices

1.15SEK+0.02 (+2.14%)

Price History

Full chart

Market Stats

Previous Close1.12
Open1.10
Day Range1.10 – 1.15
52-Week Range0.4105 – 1.11
Volume418.50K
Market Cap432.79M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.10
Dividend Yield0.00%
Beta1.46
50-Day Avg0.8522
200-Day Avg0.7077

About

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter; Cooral system provides medical professionals a way to reduce the risk of oral mucositis; and IQool system, a temperature management system that monitors and controls a patient's temperature. In addition, the company provides products for medical cooling treatments for diseases, such as stroke, cardiac arrest, migraine, and oral mucositis. BrainCool AB (publ) was incorporated in 2010 and is based in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Anna Lindstrom
  • Employees15
  • HeadquartersMedicon Village, Lund, Sweden, 223 81, Sweden
  • Websitehttps://braincoolinc.com

Leadership

  • Ms. Anna LindstromChief Executive Officer · b. 1976
  • Ms. Lotta ValfridssonChief Financial Officer · b. 1972
  • Mr. Jon BergChief Operating Officer
  • Ms. Klara RasmussonCCO & Head of Clinical Affairs

Financials

Income Statement

Currency: SEK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue779.73K998.79K1.29M4.26M7.03M9.26M17.59M23.23M39.96M36.21M
Growth (%)-+28.09%+28.88%+230.63%+65.23%+31.74%+89.85%+32.06%+72.05%-9.38%
Cost of Revenue15.45M24.31M40.43M54.89M43.77M58.19M63.75M11.11M26.83M77.09M
Gross Profit-14.67M-23.31M-39.14M-50.64M-36.74M-48.93M-46.16M12.12M13.13M-40.88M
Gross Margin-1881.80%-2333.88%-3040.76%-1189.80%-522.45%-528.10%-262.43%52.16%32.86%-112.88%
Operating Expense-3-53.50M2.40M2.17M2.17M2.43M66.28M55.32M-6.45M
Operating Income-14.67M-23.31M-42.64M-53.04M-38.91M-51.10M-48.59M-54.16M-42.19M-34.43M
Operating Margin-1881.80%-2333.88%-3312.65%-1246.27%-553.37%-551.58%-276.24%-233.18%-105.58%-95.07%
EBITDA-12.47M-18.64M-27.61M-50.71M-30.39M-32.16M-35.07M-49.86M-34.06M-29.99M
EBITDA Margin-1599.78%-1866.72%-2144.58%-1191.48%-432.19%-347.11%-199.40%-214.66%-85.22%-82.80%
Net Income-13.48M-23.08M-38.94M-57.28M-37.30M-38.75M-45.61M-61.28M-44.04M-37.05M
Net Income Margin-1729.09%-2310.96%-3025.03%-1345.90%-530.49%-418.27%-259.34%-263.81%-110.21%-102.31%
R&D---2.20M2.17M2.17M2.26M---
R&D as % of Total Revenue---51.64%30.92%23.47%12.85%---
Interest Expense116.16K1.29M627.03K4.11M4.17M3.31M8.05M618.33K7.29M3.88M
Interest Expense % of Total Revenue14.90%129.61%48.71%96.58%59.30%35.72%45.74%2.66%18.24%10.73%

Balance Sheet

Currency: SEK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets62.80M91.65M64.66M83.66M94.28M99.35M133.67M133.28M162.04M192.38M
Total Liabilities16.50M23.06M18.24M42.54M33.58M54.12M17.44M21.54M16.11M16.58M
Total Equity46.30M68.59M46.42M41.11M60.70M45.23M116.23M111.74M145.93M175.80M
Cash6.37M28.44M820.42K13.37M12.02M13.58M41.21M25.06M31.40M39.57M
Total Debt1.83M16.08M8.47M1.18M-35.00M----
Net Debt-4.54M-12.36M7.65M-12.20M-12.02M21.42M-41.21M-25.06M-31.40M-39.57M

Cash Flow

Currency: SEK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-15.19M-29.14M-25.28M-56.01M-39.25M-24.25M-46.27M-61.16M-62.64M-52.68M
Investing Cash Flow-16.87M-8.32M-11.27M-6.12M-8.37M-10.82M-7.59M-6.17M-7.57M-6.54M
Financing Cash Flow32.73M59.53M8.91M74.68M46.57M36.39M81.28M50.93M76.80M67.33M
Capital Expenditure7.79M8.32M11.27M6.12M7.57M10.82M7.40M6.07M7.57M3.81M
Free Cash Flow-22.98M-37.46M-36.55M-62.13M-46.82M-35.06M-53.67M-67.23M-70.20M-56.49M
FCF to OCF151.33%128.54%144.56%110.92%119.27%144.60%115.99%109.93%112.08%107.24%

Earnings

Report DateJun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Nov 27, 2024Feb 26, 2025May 2, 2025Aug 15, 2025Nov 3, 2025Feb 18, 2026May 6, 2026Aug 13, 2026
EPS Estimate------------------------------------------0.04-0.03-0.00--
EPS Actual-0.04-0.07-0.27-0.06-0.08-0.12-0.11-0.11-0.10-0.10-0.15-0.24-0.18-0.10-0.14-0.14-0.18-0.15-0.42-0.24-0.29-0.24-0.36-0.19-0.12-0.10-0.14-0.09-0.11-0.09-0.19-0.11-0.14-0.08-0.06-0.05-0.07-0.05-0.05-0.04-0.03-0.03-0.04-0.04-0.03-0.02-0.02
Surprise-----------------------------------------25.00%-33.33%----
Timing-----------------------------------------Pre-marketPre-market-Pre-market--

Key Statistics & Ratios

Market Cap432.79M
Enterprise Value378.64M
Trailing P/E0.00
Forward P/E0.00
Price / Sales9.31
Price / Book2.65
EPS-0.10
Book Value0.403
Revenue (TTM)46.49M
Gross Profit (TTM)12.61M
EBITDA-31.22M
Profit Margin-74.07%
Operating Margin-74.47%
Return on Equity-24.11%
Return on Assets-12.89%
Shares Outstanding394.88M
Shares Float357.33M
Beta1.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%